NTRK Fusion Gene Positive Advanced Solid Tumor Market Overview

Ajouter une nouvelle offre d'emploi Health

2026-07-01 10:55:49 -

The NTRK Fusion Gene Positive Advanced Solid Tumor Market is poised for substantial growth, valued at USD 2,500 million in 2024 and projected to reach USD 8.0 billion by 2035 at a CAGR of 11.0%. NTRK gene fusions are rare but oncogenic drivers found across multiple tumor types, making them attractive targets for precision oncology therapies. The market encompasses treatment types including...

0 Commentaires 0 Parts 111 Vue 0 Aperçu